Replies to post #436050 on Amarin Corp Plc (AMRN)

[Tatsumaki]

Yet here everyone is 5 years after the fraud on the court with the cropped chart that negated Amarin's patent... The generics continue to sell. Amarin is down 99%. No government agency has cared, nor will care unless a bigger issue occurs to pull them in. Meanwhile, politicians campaign every 2, 4, 6 years on making drugs cheaper for grandma so she doesnt have to decide on paying for meds or food and push generics that generate competition for the greedy brand name drug companies.

Makes me laugh when 99.99% of this board likely take a wide array of generic drugs without a 2nd thought, but when it's the one drug that shafted your personal investment it's crusade time. Do you all still demand and pay out of pocket for brand statins?

When the FDA, FTC, Congress or ANY public agency takes up Amarin's case out of the blue on their own accord out of the goodness of their heart to do best for the American healthcare consumer or because Amarin was done dirty, I'll give you full credit for being right. Until then, I'm not gonna hold my breath on any of them caring about Amarin or Brand V. Im certainly not going to buy shares hoping any of that will happen.

Generics have yet to beat the $36 per year that I paid for Vascepa for many years prior to 7/1/2024

That's what YOU pay. How much did your insurer pay to procure brand vs how much did your insurer pay to procure generic? They'll never tell you. Fact is, generics is their lowest cost. If brand were cheaper for them to procure, you'd get brand. The fact you pay more is entirely between you and the insurer. Has nothing to do with your copay.

Enron had an insider whistleblower go public, it was an enormous public scandal. Company went BK. 25k people lost jobs. 3-4B in pensions lost. Shafted several large institutional shareholders and was the poster child for sins of deregulation of the public utility industry. Made a lot of waves, got a lot of attention. Nightly news stories. It was a S&L brouhaha. That's why it got the full treatment and attention. Amarin isn't even in the same league. It's just some brand drug that lost a patent and went generic and shareholders are butthurt. Boo hoo. Nobody cares but people on this board. The old CEO cashed out $40M. He don't care!

Your fraud case from 1944? Only person that'll care is a judge if it ever makes it into court. To date, Amarin hasn't bothered to pursue fraud on the court. Irate shareholders didnt have standing. So moot point. OIC isnt going to look at that and say "hey, we should go after Amarin cause the SC in the '40s overturned some glass company ruling!"

Hikma's product has not been shown to be a "therapeutic" equivalent of Vascepa

It is for the Marine label. They pointed out it isnt approved for Reduce It label, but generic product is 100% legal to put on the market with the Marine label. Dr's and insurers will use it at will however they want, including cvd uses unless someone sues THEM and stops THEM which isnt going to happen. I posted 4 years ago that the day generics hit the market it'll get used for everything and nothing will stop it. Realistically, it's a time game. The generics have time, Amarin doesnt.

The half-life of generic products is half that of Vascepa.

You mean shelf life in the bottle/capsule? Maybe true... but that's a function of the capsule and impurity profile of the product. All the FDA cares about is the generic delivered at least 80% of the product to the blood stream within the stated shelf life of the product label and that's good enough for them to market it as a generic equivalent. It's bioequivalent. That's the legal standard. FDA doesnt care if Hikma's shelf life is 18 months and Amarin's is 36 months. They'll just tell you to use generic before it's out of date. Same with insurers. FDA doesnt care if the impurity profile is different. It's bioequivalent unless someone can prove to them it isnt. Amarin isnt pushing that. FDA isnt going to research it on their own. The only time FDA will take action on their own is if there's a contaminant that causes direct harm or mislabeled/misbranded product or someone like Gottlieb wants a board seat in industry.

And Purdue... are you seriously comparing the oxycotin / pill mill scandal with millions of deaths and opoid zombies roaming our inner cities to this day to Amarin's situation? Once again... Amarin losing their patents it doesnt even come close to ringing the bells needed to trigger that kind of government response. There is no enormous public outcry. But hey, since you brought it up, how did Purdue get their drug approved in the first place? Corrupt FDA officials...